DK170780B1 - Substituerede guaninnucleosidderivater, immunreaktionsforstærkende præparater deraf, og fremgangsmåde til at forøge en immunreaktion - Google Patents

Substituerede guaninnucleosidderivater, immunreaktionsforstærkende præparater deraf, og fremgangsmåde til at forøge en immunreaktion Download PDF

Info

Publication number
DK170780B1
DK170780B1 DK217289A DK217289A DK170780B1 DK 170780 B1 DK170780 B1 DK 170780B1 DK 217289 A DK217289 A DK 217289A DK 217289 A DK217289 A DK 217289A DK 170780 B1 DK170780 B1 DK 170780B1
Authority
DK
Denmark
Prior art keywords
substituted
group
groups
oxoguanosine
cells
Prior art date
Application number
DK217289A
Other languages
Danish (da)
English (en)
Other versions
DK217289D0 (da
DK217289A (da
Inventor
Michael Goodman
Robert Chen
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of DK217289D0 publication Critical patent/DK217289D0/da
Publication of DK217289A publication Critical patent/DK217289A/da
Application granted granted Critical
Publication of DK170780B1 publication Critical patent/DK170780B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK217289A 1988-05-05 1989-05-03 Substituerede guaninnucleosidderivater, immunreaktionsforstærkende præparater deraf, og fremgangsmåde til at forøge en immunreaktion DK170780B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/190,694 US5093318A (en) 1983-11-01 1988-05-05 Immunostimulating guanosine derivatives and their pharmaceutical compositions
US19069488 1988-05-05

Publications (3)

Publication Number Publication Date
DK217289D0 DK217289D0 (da) 1989-05-03
DK217289A DK217289A (da) 1989-11-06
DK170780B1 true DK170780B1 (da) 1996-01-15

Family

ID=22702383

Family Applications (1)

Application Number Title Priority Date Filing Date
DK217289A DK170780B1 (da) 1988-05-05 1989-05-03 Substituerede guaninnucleosidderivater, immunreaktionsforstærkende præparater deraf, og fremgangsmåde til at forøge en immunreaktion

Country Status (12)

Country Link
US (1) US5093318A (pt)
EP (1) EP0341066B1 (pt)
JP (1) JP2790846B2 (pt)
AT (1) ATE113957T1 (pt)
AU (1) AU619539B2 (pt)
CA (1) CA1320196C (pt)
DE (1) DE68919266T2 (pt)
DK (1) DK170780B1 (pt)
ES (1) ES2063125T3 (pt)
GR (1) GR3015018T3 (pt)
IE (1) IE66321B1 (pt)
PT (1) PT90464B (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011828A (en) * 1985-11-15 1991-04-30 Michael Goodman Immunostimulating guanine derivatives, compositions and methods
US6060459A (en) * 1987-10-28 2000-05-09 Pro-Neuron, Inc. Enhancing blood cell count with oxypurine nucleosides
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
AU5165793A (en) * 1992-10-01 1994-04-26 Mcneilab, Inc. Derivatives of 7,8-disubstituted guanosines
US6727230B1 (en) * 1994-03-25 2004-04-27 Coley Pharmaceutical Group, Inc. Immune stimulation by phosphorothioate oligonucleotide analogs
US5786359A (en) * 1994-05-27 1998-07-28 The Scripps Research Institute N9 alkyl or aralkyl derivatives of 7, 8-disubstituted guanines
US5382580A (en) * 1994-05-27 1995-01-17 The Scripps Research Institute N9 morpholino derivatives of 7,8-disubstituted guanines
US5441942A (en) * 1994-05-27 1995-08-15 The Scripps Research Institute 2'3'-dideoxy-2',3'-didehydro-7,8-disubstituted guanosines and their immunostimulative effect
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US5773424A (en) * 1994-12-16 1998-06-30 Research Corporation Technologies, Inc. Treatment of toxoplasmosis
US20030100520A1 (en) * 1997-01-21 2003-05-29 Philip Needleman Immunological process and constructs for increasing the hdl cholesterol concentration by dna vaccination
US6303617B1 (en) 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
AU4244400A (en) * 1999-04-15 2000-11-02 Board Of Regents, The University Of Texas System Ppgpp and pppgpp as immunomodulatory agents
US6949520B1 (en) * 1999-09-27 2005-09-27 Coley Pharmaceutical Group, Inc. Methods related to immunostimulatory nucleic acid-induced interferon
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US20010044416A1 (en) * 2000-01-20 2001-11-22 Mccluskie Michael J. Immunostimulatory nucleic acids for inducing a Th2 immune response
US7585847B2 (en) * 2000-02-03 2009-09-08 Coley Pharmaceutical Group, Inc. Immunostimulatory nucleic acids for the treatment of asthma and allergy
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) * 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
ES2385931T3 (es) 2000-07-07 2012-08-03 Spectrum Pharmaceuticals, Inc. MÉTODOS PARA EL TRATAMIENTO DE NEUROPATíA PERIFÉRICA INDUCIDA POR UNA ENFERMEDAD Y AFECCIONES RELACIONADAS.
US20030138769A1 (en) * 2000-08-16 2003-07-24 Birkett Ashley J. Immunogenic HBc chimer particles having enhanced stability
ATE398175T1 (de) * 2000-12-08 2008-07-15 Coley Pharmaceuticals Gmbh Cpg-artige nukleinsäuren und verfahren zu ihrer verwendung
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
US7361352B2 (en) * 2001-08-15 2008-04-22 Acambis, Inc. Influenza immunogen and vaccine
US20030175863A1 (en) * 2001-08-15 2003-09-18 Birkett Ashley J. Influenza immunogen and vaccine
US20030185858A1 (en) * 2001-08-15 2003-10-02 Birkett Ashley J. Immunogenic HBc chimer particles stabilized with an N-terminal cysteine
US7351413B2 (en) * 2002-02-21 2008-04-01 Lorantis, Limited Stabilized HBc chimer particles as immunogens for chronic hepatitis
WO2004087203A2 (en) * 2003-04-02 2004-10-14 Coley Pharmaceutical Group, Ltd. Immunostimulatory nucleic acid oil-in-water formulations for topical application
CN101268092B (zh) * 2005-09-22 2012-07-04 弗·哈夫曼-拉罗切有限公司 核苷的选择性o-酰基化
HUE025149T2 (hu) * 2007-08-02 2016-01-28 Biondvax Pharmaceuticals Ltd Multimer multiepitóp influenza vakcinák
EP2722056A1 (en) 2007-12-03 2014-04-23 President and Fellows of Harvard College CT062, a Chlamydia antigen
CN102239253A (zh) 2008-12-03 2011-11-09 普罗蒂亚维仕尼科技有限公司 谷氨酰tRNA合成酶（GtS）片段
WO2011067758A2 (en) 2009-12-02 2011-06-09 Protea Vaccine Technologies Ltd. Immunogenic fragments and multimers from streptococcus pneumoniae proteins
US9303070B2 (en) 2011-02-22 2016-04-05 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
EP2833900B1 (en) 2012-04-01 2018-09-19 Technion Research & Development Foundation Limited Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies
US10426828B2 (en) 2014-04-03 2019-10-01 Biondvax Pharmaceuticals Ltd. Compositions of multimeric-multiepitope influenza polypeptides and their production
BR112020023866A2 (pt) 2018-05-25 2021-04-06 Primmune Therapeutics, Inc. Agonistas de tlr7

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948730A (en) * 1982-11-09 1990-08-14 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4539205A (en) * 1982-11-09 1985-09-03 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4643992A (en) * 1982-11-09 1987-02-17 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5011828A (en) * 1985-11-15 1991-04-30 Michael Goodman Immunostimulating guanine derivatives, compositions and methods

Also Published As

Publication number Publication date
CA1320196C (en) 1993-07-13
GR3015018T3 (en) 1995-05-31
DK217289D0 (da) 1989-05-03
ES2063125T3 (es) 1995-01-01
PT90464B (pt) 1994-12-30
IE891463L (en) 1989-11-05
EP0341066A3 (en) 1990-05-30
JP2790846B2 (ja) 1998-08-27
EP0341066A2 (en) 1989-11-08
JPH0256496A (ja) 1990-02-26
AU3399989A (en) 1989-11-09
DE68919266D1 (de) 1994-12-15
IE66321B1 (en) 1995-12-27
DK217289A (da) 1989-11-06
US5093318A (en) 1992-03-03
DE68919266T2 (de) 1995-06-01
AU619539B2 (en) 1992-01-30
ATE113957T1 (de) 1994-11-15
EP0341066B1 (en) 1994-11-09
PT90464A (pt) 1989-11-30

Similar Documents

Publication Publication Date Title
DK170780B1 (da) Substituerede guaninnucleosidderivater, immunreaktionsforstærkende præparater deraf, og fremgangsmåde til at forøge en immunreaktion
DK170779B1 (da) Substituerede guaninnucleosidderivater, immunreaktionsforstærkende præparater deraf, fremgangsmåde til forstærkning af en immunreaktion, anvendelse af derivaterne til fremstilling af et farmaceutisk præparat og fremgangsmåde til fremstilling af substituerede guaninnucleosidderivater
CA2494340C (en) Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae infections
ES2627903T3 (es) Profármacos de análogos de nucleótidos de fosfonato y métodos para seleccionar y preparar los mismos
JPH07113025B2 (ja) 治療用ヌクレオシド
HU199155B (en) Process for producing adenosine-5'-carboxamide derivatives and pharmaceutical compositions comprising same
CA2748034A1 (en) Purified 2'-deoxy'2'-fluoro-2'-c-methyl-nucleoside-phosphoramidate prodrugs for the treatment of viral infections
JPH10507772A (ja) Ｌ−リボフラノシルヌクレオシド
EP0343945A2 (en) Immunostimulating 7-deaza-7-oxa-and 7-deaza-7-thia-analogs of 8-substituted-guanine-9-(1'-beta-d-aldoglycosidyl) derivatives, compositions and methods
US5212161A (en) Derivatives of 2'-deoxyuridine substituted in the 5-,3'-or 5'-position by α-aminacyl groups, process for their preparation and drugs in which they are present
US5786359A (en) N9 alkyl or aralkyl derivatives of 7, 8-disubstituted guanines
WO1994007904A1 (en) Derivatives of 7,8-disubstituted guanosines
US5382580A (en) N9 morpholino derivatives of 7,8-disubstituted guanines
US5441942A (en) 2'3'-dideoxy-2',3'-didehydro-7,8-disubstituted guanosines and their immunostimulative effect
FI109129B (fi) Menetelmä 2-substituoitujen adenosiinien valmistamiseksi, joilla on A-2-reseptoriaffiniteetti
EP0748312B1 (en) Bicyclic carbamates as leukotriene d4 antagonists
US4900675A (en) Modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-β-aldoglycosidyl) derivatives
JPS63502113A (ja) イソキサントプテリン−８−（１′−β−アルドグリコシジル）誘導体を含む組成物による動物細胞応答の変調
JPH11512735A (ja) プリンとグアニンの誘導体
EP0456514A1 (en) 2-Fluoroneplanocin A and its production

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK